← Stocks · GTBP page
Price chart & company basics · Trifecta Signals
Price refreshes every trading day after the close.
Full interactive chart ↗ · partner link
Daily closes · through the most recent close
Price history from Jan 2018 · Signal tracking began Jan 2022
The Trifecta List
GT has never had a Trifecta signal in the record — not an Early signal, not a confirmed one — since the record began in January 2022. It is scanned after every trading day’s close along with the full US-listed universe; so far it has never met the conditions.
That’s the whole record for this stock: the chart and the basics above, and nothing to grade.
The list is the public track record: every stock that has signaled, logged, confirmed, and graded.
GT Biopharma is a listed company whose shares trade under the GTBP ticker.
Over the past year the shares have traded between $0.55 and $20, and the latest close sits near the bottom of that range. That is a trading range of about 3587% from low to high. Price history on this page reaches back to March 2018.
GTBP closed Thursday, November 5 at $4.64, down 4.2% on the day. Over the past week, the shares have traded in a range between about $4.64 and $5.32.
